Cargando…

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease

Accurate biomarkers of Alzheimer’s disease (AD) are essential for early diagnosis and intervention. Available biomarkers are not sufficient to permit the monitoring of AD progression over time, and additional biomarkers are required. Measures of aggregated amyloid-β (Aβ) could be useful biomarkers f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksnes, Mari, Tiiman, Ann, Edwin, Trine Holt, Terenius, Lars, Bogdanović, Nenad, Vukojević, Vladana, Knapskog, Anne-Brita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820807/ https://www.ncbi.nlm.nih.gov/pubmed/33488383 http://dx.doi.org/10.3389/fnagi.2020.608628

Ejemplares similares

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer’s Disease in a Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2020)

Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2022)

Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer’s Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis
por: Tiiman, Ann, et al.
Publicado: (2019)

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
por: Müller, Ebba Gløersen, et al.
Publicado: (2019)

Small Molecule Decoys of Aggregation for Elimination of Aβ-Peptide Toxicity
por: Oasa, Sho, et al.
Publicado: (2023)

A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
por: Edwin, Trine Holt, et al.
Publicado: (2020)

Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2023)

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease
por: Henjum, Kristi, et al.
Publicado: (2022)

Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
por: Knapskog, Anne-Brita, et al.
Publicado: (2017)

Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification
por: Knapskog, Anne-Brita, et al.
Publicado: (2020)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

The interwoven fibril-like structure of amyloid-beta plaques in mouse brain tissue visualized using super-resolution STED microscopy
por: Johansson, Björn, et al.
Publicado: (2023)

Iso-α-acids in Nonalcoholic and Alcoholic Beer Stimulate Growth of Neuron-like SH-SY5Y Cells and Neuroepithelial Stem Cells
por: Laurent, Agneta J., et al.
Publicado: (2021)

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
por: Tangen, Gro Gujord, et al.
Publicado: (2023)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

Smallest Secondary Nucleation Competent Aβ Aggregates Probed by an ATP-Independent Molecular Chaperone Domain
por: Leppert, Axel, et al.
Publicado: (2021)

Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells
por: Vukojević, Vladana, et al.
Publicado: (2008)

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
por: Zettergren, Anna, et al.
Publicado: (2019)

Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
por: Mjørud, Marit, et al.
Publicado: (2020)

A strategy for designing allosteric modulators of transcription factor dimerization
por: Oasa, Sho, et al.
Publicado: (2020)

Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT(1A)) Receptors Heterodimerization and Cellular Effectors (Ca(2+), ERK1/2 and p38) Activation
por: Radoi, Vlad, et al.
Publicado: (2022)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
por: Zhao, Jing, et al.
Publicado: (2020)

Nanoscale Effects of Ethanol and Naltrexone on Protein Organization in the Plasma Membrane Studied by Photoactivated Localization Microscopy (PALM)
por: Tobin, Steven J., et al.
Publicado: (2014)

Control of Hox transcription factor concentration and cell-to-cell variability by an auto-regulatory switch
por: Papadopoulos, Dimitrios K., et al.
Publicado: (2019)

Mapping the Direction of Nucleocytoplasmic Transport of Glucocorticoid Receptor (GR) in Live Cells Using Two-Foci Cross-Correlation in Massively Parallel Fluorescence Correlation Spectroscopy (mpFCS)
por: Nikolić, Stanko N., et al.
Publicado: (2023)

Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
por: Strand, Bjørn Heine, et al.
Publicado: (2018)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
por: Bellomo, Giovanni, et al.
Publicado: (2021)

Core Alzheimer’s disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods
por: Doecke, James D., et al.
Publicado: (2021)

Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures
por: Persson, Karin, et al.
Publicado: (2023)

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
por: Bonito‐Oliva, Alessandra, et al.
Publicado: (2019)

Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
por: Waragai, Masaaki, et al.
Publicado: (2020)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients
por: Watne, Leiv Otto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nltj53dn51ag9mc6o7i9tn3hj4